Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 32,490

Document Document Title
WO/2021/071248A1
The present specification provides a heterocyclic compound represented by chemical formula 1, an organic light-emitting diode comprising same, a composition for an organic layer of an organic light-emitting diode, and a method for manufa...  
WO/2021/071255A1
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device including the organic electronic element. According to the present invention, an organic el...  
WO/2021/068943A1
Disclosed in the present invention are a substituted nitrogen heterocyclic compound and anesthetic action thereof. Specifically provided are a chemical compound as shown in formula I, a stereoisomer thereof, a pharmaceutically acceptable...  
WO/2021/069184A1
The present invention relates to a compound of formula (I), to the use thereof in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.  
WO/2021/068511A1
Disclosed is a preparation method of D-A type carbazolyl derivatives and luminescent properties thereof. The carbazolyl derivatives have a structural general formula represented by formula (I). The D-A type structure comprises carbazole ...  
WO/2021/068828A1
The invention provides a chemiluminescence substrate having high luminescence intensity, a long wavelength, and good stability, and a preparation method therefor and an application thereof. The chemiluminescence substrate has a structure...  
WO/2021/065350A1
Provided are: a radiation-sensitive resin composition having excellent performance in terms of sensitivity, LWR, etc., in an exposure step even when a next-generation exposure technique is applied; and a method for forming a resist patte...  
WO/2021/065980A1
Provided is a BET degrader. A BET degrader including a compound represented by formula (I) or a pharmaceutically acceptable salt thereof is used. (In the formula, L1 and L2 are the same or different and represent a low molecular ligand f...  
WO/2021/066351A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2021/064142A1
The present invention relates to a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof : formula (I) and to pharmac...  
WO/2021/066350A1
The present invention provides: a compound represented by chemical formula 1; and an organic light emitting device which has increased efficiency, low driving voltage, and/or improved service life characteristics by using the compound as...  
WO/2021/067801A1
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or prodrug, and/or tautomer, and/or drug combination of the compound) that inhibit (e.g., antagoniz...  
WO/2021/067654A1
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.  
WO/2021/058754A1
The invention provides a composition of matter which: • (i) consists of at least 90 % by weight of an atropisomer (2A) and 0-10 % by weight of an atropisomer of formula (2B); or • (ii) consists of at least 90 % by weight of an atropi...  
WO/2021/059086A1
Provided is a novel organic compound. Provided is an organic compound represented by general formula (G1). (In general formula (G1), either A or B is a group represented by the general formula (g1). Furthermore, the other of A and B, R1...  
WO/2021/060723A1
The present invention provides: a compound represented by chemical formula 1; an organic electronic element comprising a first electrode, a second electrode, and an organic layer placed between the first and second electrodes; and an ele...  
WO/2021/060281A1
The purpose of the present invention is to provide a novel compound which has a prostaglandin E2 (PGE2) receptor EP2/EP4 dual antagonizing effect and is useful as: a preventive or therapeutic agent for a disease selected from cancer, pai...  
WO/2021/060236A1
The present invention relates to: a compound represented by formula (I) or a salt thereof; and a herbicide that contains at least one of the foregoing as an active ingredient. In formula (I), R1 is a substituted or unsubstituted C1-6 alk...  
WO/2021/060193A1
This compound represented by formula (1) (the respective signs in the formula are as defined in the description) provides an organic electroluminescent element having improved performance.  
WO/2021/057190A1
The present invention relates to quinoline compounds, a preparation method therefor and a use thereof. Specifically, provided are novel quinoline compounds, and pharmaceutically-acceptable salts thereof, a preparation method therefor, an...  
WO/2021/060890A1
The present invention relates to a heteroarylamidopyridinol derivative and a pharmaceutical composition comprising same as an active ingredient for prevention or treatment of an autoimmune disease, specifically, inflammatory bowel diseas...  
WO/2021/053344A1
There is provided herein a compound of formula I, wherein R1, R2, R3 Y1, Y2, Y3, Y4, R4, R5 and R6 are as defined herein, which compounds are useful in the treatment of autoimmune and/or fibrotic diseases, including interstitial lung dis...  
WO/2021/051231A1
Disclosed is a new class of photo-responsive coordination compounds with at least one photochromic unit on a coordinating ligand. The photo-responsive coordination compounds are shown to be capable of acting as electroactive materials fo...  
WO/2021/055376A1
The disclosure herein provides compounds and pharmaceutical compositions for the modulation of IL-17A useful for the treatment of inflammatory conditions, such as psoriasis.  
WO/2021/049819A1
The present invention provides a novel compound, and an organic light-emitting device comprising same.  
WO/2021/050915A1
The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods ...  
WO/2021/047553A1
An aromatic heterocyclic compound having a tricyclic structure, and a preparation method therefor and application thereof, and in particular, a compound as shown in formula I, or an optical isomer, a hydrate, a solvate, or a pharmaceutic...  
WO/2021/050994A1
Provided herein are heterobicyclic cyclopropanecarboxamide and heterobicyclic carboxamide compounds. In particular, provided herein are compounds that affect the function of kinases in a cell, and that are useful as therapeutic agents or...  
WO/2021/045347A1
The present invention provides a compound represented by chemical formula 1 and an organic light emitting device comprising same. The compound represented by chemical formula 1 may be used as a hole injection, hole transport, electron bl...  
WO/2021/043077A1
(I) The present invention relates to a substituted pyrazine compound used as an SHP2 phosphatase inhibitor. Specifically, the present invention relates to the compound of formula (I) or a pharmaceutically acceptable salt, an ester, a ste...  
WO/2021/043755A1
The invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.  
WO/2021/045444A1
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrod...  
WO/2020/061375A8
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting the growth of gram -negative bacteria. Furthermore, the subject compounds and compositions are...  
WO/2021/009334A3
The present invention relates to herbicidal substituted phenyl-pyridazine-diones and substituted phenyl-pyridazinone derivatives of formula (I), as well as to processes and intermediates used for the preparation of such derivatives. The ...  
WO/2021/036851A1
The present disclosure relates to the technical field of electronic components, and provided therein are a nitrogen-containing compound represented by formula (I), an organic electroluminescent device and a photoelectric conversion devic...  
WO/2021/039824A1
An RNA methyltransferase inhibitor containing at least one type of compound selected from the group consisting of sulfonamide-based compounds represented by general formula (1) and pyrazoline-based compounds represented by general formul...  
WO/2021/040467A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2021/034039A1
The present application provides: a heterocyclic compound capable of significantly improving the lifespan, efficiency, electrochemical stability, and thermal stability of an organic light-emitting device; and an organic light-emitting de...  
WO/2021/032938A1
The present invention provides compounds of formula (I) or (Ia) compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients with such compounds; wherein A, B, n, R2, R3, R4, R5, and R6 a...  
WO/2021/032935A1
The present invention provides compounds of formula (I) or (Ia): compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients with such compounds; wherein A, B, n, R2, R3, R4, R5, and R6 ...  
WO/2021/033731A1
Provided is a compound which is represented by formula (1). In the formula, R1-R14, L1-L3, p, q, r, n, and X1 are as defined in the specification.  
WO/2021/032643A1
The present invention relates to a compound of the general formula I and the pharmaceutically acceptable salts thereof; where the variables are as defined in the claims and the description. The invention also relates to the compounds of ...  
WO/2021/034156A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2021/034089A1
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device including the organic electronic element. According to the present invention, an organic el...  
WO/2021/033724A1
This compound, which is represented by formula (1), provides an organic electroluminescent element that has further improved element performance. (In the formula, X1, X2, Y1~Y3, L, *a, R1~R9, R11...  
WO/2021/033730A1
Provided are: a compound that further improves organic EL element performance; an organic electroluminescence element having element performance further improved, and an electronic device including said organic electroluminescence elemen...  
WO/2021/029715A1
The present invention provides a novel compound and an organic light emitting device comprising same.  
WO/2021/027304A1
The present invention relates to a bi-heterocyclic methylethylamine substituted oxaspiro derivative, a preparation method therefor, and a pharmaceutical use thereof. In particular, disclosed are a compound of formula (I) or a pharmaceuti...  
WO/2021/029598A1
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode; and an...  
WO/2021/029634A1
The present invention provides a novel compound, and an organic light-emitting element using same.  

Matches 1 - 50 out of 32,490